---
title: "Navamedic ASA: Invitation to 2024 4th quarter presentation"
date: "2025-02-10 18:00:43"
summary: "Oslo, February 10, 2025 - Navamedic ASA (OSE: Nava) will be presenting its 4thquarter 2024 results on Wednesday, February 12, 2025. The presentation will beheld at Haakon VIIs gate 2 in Oslo and the event will start at 08.30 CET. Alinkto the webcast and the presentation will be available through..."
categories:
  - "Reuters"
lang:
  - "en"
translations:
  - "en"
tags:
  - "Reuters"
menu: ""
thumbnail: ""
lead: ""
comments: false
authorbox: false
pager: true
toc: false
mathjax: false
sidebar: "right"
widgets:
  - "search"
  - "recent"
  - "taglist"
---

Oslo, February 10, 2025 - Navamedic ASA (OSE: Nava) will be presenting its 4thquarter 2024 results on Wednesday, February 12, 2025. The presentation will beheld at Haakon VIIs gate 2 in Oslo and the event will start at 08.30 CET. Alinkto the webcast and the presentation will be available through the Navamedicwebsite on the following link: https://navamedic.com/investors/financial-results/

For further information, please contact:

Kathrine Gamborg Andreassen, CEO, +47 951 78 680 E-mail:kathrine@navamedic.com

Lars Hjarrand, CFO, +47 917 62 842 E-mail: lars.hjarrand@navamedic.com

About Navamedic: Navamedic ASA is a full-service provider of high-qualityhealthcare products to hospitals and pharmacies. Navamedic meets the specificmedical needs of patients and consumers by leveraging its highly scalablemarketaccess platform, leading category competence and local knowledge. Navamedic ispresent in all the Nordic countries, the Baltics and Benelux, with salesrepresentation in the UK and Greece. Navamedic is headquartered in Oslo,Norway,and listed on the Oslo Stock Exchange (ticker: NAVA). For more information,please visit www.navamedic.com

https://newsweb.oslobors.no/message/638127

[Reuters](https://www.tradingview.com/news/reuters.com,2025-02-10:newsml_ObiPVD7Ha:0-navamedic-asa-invitation-to-2024-4th-quarter-presentation/)
